{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T13:32:18Z","timestamp":1778074338861,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T00:00:00Z","timestamp":1389830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s11920-013-0431-y","type":"journal-article","created":{"date-parts":[[2014,1,15]],"date-time":"2014-01-15T06:15:29Z","timestamp":1389766529000},"source":"Crossref","is-referenced-by-count":39,"title":["Options for Pharmacological Treatment of Refractory Bipolar Depression"],"prefix":"10.1007","volume":"16","author":[{"given":"Leonardo","family":"Tondo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo H.","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross J.","family":"Baldessarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,16]]},"reference":[{"issue":"3","key":"431_CR1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/10673221003747955","volume":"18","author":"RJ Baldessarini","year":"2010","unstructured":"\u2022 Baldessarini RJ, Vieta E, Calabrese JR, et al. Bipolar depression: overview and commentary. Harv Rev Psychiatry. 2010;18(3):143\u201357. Overview on bipolar depression.","journal-title":"Harv Rev Psychiatry"},{"issue":"6","key":"431_CR2","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","volume":"59","author":"LL Judd","year":"2002","unstructured":"Judd LL, Akiskal HS, Schettler PJ, et al. Long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry. 2002;59(6):530\u20137.","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"431_CR3","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4088\/JCP.v64n0610","volume":"64","author":"RM Post","year":"2003","unstructured":"Post RM, Denicoff KD, Leverich GS, et al. Morbidity in 258 bipolar outpatients followed for 1year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry. 2003;64(6):680\u201390.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"431_CR4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1399-5618.2003.00091.x","volume":"6","author":"RT Joffe","year":"2004","unstructured":"Joffe RT, MacQueen GM, Marriott M, et al. Prospective, longitudinal study of percentage of time spent ill in patients with bipolar I or bipolar II disorders. Bipolar Disord. 2004;6(1):62\u20136.","journal-title":"Bipolar Disord"},{"issue":"8","key":"431_CR5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1192\/bjp.bp.105.013870","volume":"189","author":"ES Paykel","year":"2006","unstructured":"Paykel ES, Abbott R, Morriss R, et al. Sub-syndromal and syndromal symptoms in the longitudinal course of bipolar disorder. Br J Psychiatry. 2006;189(8):118\u201323.","journal-title":"Br J Psychiatry"},{"issue":"3","key":"431_CR6","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1399-5618.2010.00812.x","volume":"12","author":"RJ Baldessarini","year":"2010","unstructured":"Baldessarini RJ, Salvatore P, Khalsa H-MK, et al. Morbidity in 303 first-episode bipolar I disorder patients. Bipolar Disord. 2010;12(3):264\u201370.","journal-title":"Bipolar Disord"},{"issue":"3","key":"431_CR7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.psychres.2013.03.022","volume":"207","author":"FK Vergunst","year":"2013","unstructured":"\u2022\u2022 Vergunst FK, Fekadu A, Wooderson SC, et al. Longitudinal course of symptom severity and fluctuation in patients with treatment-resistant unipolar and bipolar depression. Psychiatry Res. 2013;207(3):143\u20139. Describes longitudinal course and severity of treatment-resistant unipolar and bipolar depression.","journal-title":"Psychiatry Res"},{"key":"431_CR8","doi-asserted-by":"crossref","unstructured":"Baldessarini RJ, Tondo L, Visioli C. First-episode types in bipolar disorder: predictive associations with later illness. Acta Psychiatr Scand. 2013; in press.","DOI":"10.1111\/acps.12204"},{"issue":"9","key":"431_CR9","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/archpsyc.58.9.844","volume":"58","author":"U \u00d6sby","year":"2001","unstructured":"\u00d6sby U, Brandt L, Correia N, et al. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry. 2001;58(9):844\u201350.","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"431_CR10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1471-244X-13-105","volume":"13","author":"U Kessler","year":"2013","unstructured":"Kessler U, Schoeyen HK, Andreassen OA, et al. Neurocognitive profiles in treatment-resistant bipolar I and bipolar II disorder depression. BMC Psychiatry. 2013;13(4):105.","journal-title":"BMC Psychiatry"},{"key":"431_CR11","doi-asserted-by":"crossref","unstructured":"Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013; [Epub ahead of print (28 Aug)].","DOI":"10.1016\/S0140-6736(13)61611-6"},{"issue":"1","key":"431_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-5618.2009.00786.x","volume":"12","author":"DM Novick","year":"2010","unstructured":"Novick DM, Swartz HA, Frank E. Suicide attempts in bipolar I and bipolar II disorder: review and meta-analysis of the evidence. Bipolar Disord. 2010;12(1):1\u20139.","journal-title":"Bipolar Disord"},{"issue":"1\u20133","key":"431_CR13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jad.2006.01.032","volume":"93","author":"F Colom","year":"2006","unstructured":"Colom F, Vieta E, Daban C, et al. Clinical and therapeutic implications of predominant polarity in bipolar disorder. J Affect Disord. 2006;93(1\u20133):13\u20137.","journal-title":"J Affect Disord"},{"issue":"4","key":"431_CR14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1600-0447.2011.01818.x","volume":"125","author":"RJ Baldessarini","year":"2012","unstructured":"Baldessarini RJ, Undurraga J, V\u00e1zquez GH, et al. Predominant recurrence polarity among 928 adult international bipolar I disorder patients. Acta Psychiatr Scand. 2012;125(4):293\u2013302.","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"431_CR15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1600-0447.2009.01471.x","volume":"120","author":"I Pacchiarotti","year":"2009","unstructured":"Pacchiarotti I, Mazzarini L, Colom F, et al. Treatment-resistant bipolar depression: towards a new definition. Acta Psychiatr Scand. 2009;120(6):429\u201340.","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"431_CR16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0193-953X(05)70285-9","volume":"19","author":"GS Sachs","year":"1996","unstructured":"Sachs GS. Treatment-resistant bipolar depression. Psychiatr Clin North Am. 1996;19(2):215\u201336.","journal-title":"Psychiatr Clin North Am"},{"issue":"7","key":"431_CR17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.euroneuro.2012.02.006","volume":"22","author":"A Schosser","year":"2012","unstructured":"\u2022 Schosser A, Serretti A, Souery D, et al. European Group for the Study of Resistant Depression (GSRD)\u2014where have we gone so far: review of clinical and genetics findings. Eur Neuropsychopharmacol. 2012;22(7):453\u201368. Reviews many aspects of treatment-resistant depression.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"431_CR18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1192\/bjp.bp.110.086983","volume":"200","author":"C-T Li","year":"2012","unstructured":"\u2022\u2022 Li C-T, Bai Y-M, Huang Y-L, et al. Association between antidepressant resistance in unipolar depression and subsequent bipolar depression: cohort study. Br J Psychiatry. 2012;200(1):45\u201351. Rare study directly comparing unipolar and bipolar treatment-resistant depression.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"431_CR19","first-page":"21","volume":"44","author":"GH V\u00e1zquez","year":"2011","unstructured":"V\u00e1zquez GH, Tondo L, Baldessarini RJ. Comparison of antidepressant responses in patients with bipolar vs. unipolar depression: meta-analytic review. Pharmacopsychiatry. 2011;44(1):21\u20136.","journal-title":"Pharmacopsychiatry"},{"issue":"5","key":"431_CR20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/acps.12023","volume":"127","author":"L Tondo","year":"2013","unstructured":"\u2022 Tondo L, Baldessarini RJ, V\u00e1zquez GH, et al. Clinical responses to antidepressants among 1036 acutely depressed patients with bipolar or unipolar major affective disorders. Acta Psychiatr Scand. 2013;127(5):355\u201364. Found that there is no difference in response in bipolar versus unipolar depression, provided that patients with agitation and dysphoric depression are not included.","journal-title":"Acta Psychiatr Scand"},{"issue":"7","key":"431_CR21","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1017\/S1461145713000023","volume":"16","author":"GH V\u00e1zquez","year":"2013","unstructured":"V\u00e1zquez GH, Tondo L, Undurraga J, et al. Overview of antidepressant treatment in bipolar depression: critical commentary. Intl J Neuropsychopharmacol. 2013;16(7):1673\u201385.","journal-title":"Intl J Neuropsychopharmacol"},{"key":"431_CR22","doi-asserted-by":"crossref","unstructured":"V\u00e1zquez GH, Tondo L, Undurraga J, et al. Pharmacological treatment for bipolar depression. Adv Psychiatr Treatment. 2013; in press.","DOI":"10.1192\/apt.bp.113.011460"},{"issue":"4","key":"431_CR23","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0269881109102919","volume":"23","author":"GM Goodwin","year":"2009","unstructured":"Goodwin GM, Consensus Group. Evidence-based guidelines for treating bipolar disorder: revised, second edition\u2014recommendations of the British Association of Psychopharmacology. J Psychopharmacol. 2009;23(4):346\u201388.","journal-title":"J Psychopharmacol"},{"issue":"1","key":"431_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bdi.12025","volume":"15","author":"LN Yatham","year":"2013","unstructured":"\u2022 Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of guidelines for management of patients with bipolar disorder. Bipolar Disord. 2013;15(1):1\u201344. Guidelines for treatment of bipolar depression.","journal-title":"Bipolar Disord"},{"key":"431_CR25","doi-asserted-by":"crossref","unstructured":"\u2022 Pacchiarotti I, Bond DJ, Baldessarini RJ, et al. International Society for Bipolar Disorders (ISBD) task-force report on antidepressant use in bipolar disorders. Am J Psychiatry 2013; in press. Major review of research on the treatment of bipolar depression","DOI":"10.1176\/appi.ajp.2013.13020185"},{"issue":"1","key":"431_CR26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1192\/bjp.bp.111.095349","volume":"200","author":"GM Goodwin","year":"2012","unstructured":"Goodwin GM. Bipolar depression and treatment with antidepressants. Br J Psychiatry. 2012;200(1):5\u20136.","journal-title":"Br J Psychiatry"},{"issue":"3","key":"431_CR27","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1176\/appi.ajp.161.3.564","volume":"161","author":"JF Goldberg","year":"2004","unstructured":"Goldberg JF, Burdick KE, Endick CJ. Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression. Am J Psychiatry. 2004;161(3):564\u20136.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"431_CR28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1176\/appi.ajp.163.2.210","volume":"163","author":"AA Nierenberg","year":"2006","unstructured":"Nierenberg AA, Ostacher MJ, Calabrese JR, et al. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry. 2006;163(2):210\u20136.","journal-title":"Am J Psychiatry"},{"issue":"8","key":"431_CR29","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1176\/appi.ajp.2007.06060981","volume":"164","author":"MA Frye","year":"2007","unstructured":"Frye MA, Grunze H, Suppes T, et al. A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. Am J Psychiatry. 2007;164(8):1242\u20139.","journal-title":"Am J Psychiatry"},{"issue":"8","key":"431_CR30","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","volume":"67","author":"N Diazgranados","year":"2010","unstructured":"Diazgranados N, Ibrahim L, Brutsche NE, et al. Randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry. 2010;67(8):793\u2013802.","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"431_CR31","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","volume":"71","author":"CA Zarate Jr","year":"2012","unstructured":"Zarate Jr CA, Brutsche NE, Ibrahim L, et al. Replication of ketamine\u2019s antidepressant efficacy in bipolar depression: randomized controlled add-on trial. Biol Psychiatry. 2012;71(5):939\u201346.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"431_CR32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/bdi.12026","volume":"15","author":"P Sienaert","year":"2013","unstructured":"Sienaert P, Lambrichts L, Dols A, et al. Evidence-based treatment strategies for treatment-resistant bipolar depression: systematic review. Bipolar Disord. 2013;15(1):61\u20139.","journal-title":"Bipolar Disord"},{"issue":"1","key":"431_CR33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1034\/j.1399-5618.2001.030103.x","volume":"3","author":"ES Brown","year":"2001","unstructured":"Brown ES, Bobadilla L, Rush AJ. Ketoconazole in bipolar patients with depressive symptoms: case series and literature review. Bipolar Disord. 2001;3(1):23\u20139.","journal-title":"Bipolar Disord"},{"issue":"Suppl 1","key":"431_CR34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000049259","volume":"45","author":"A Erfurth","year":"2002","unstructured":"Erfurth A, Michael N, Stadtland C, Arolt V. Bupropion as add-on strategy in difficult-to-treat bipolar depressive patients. Neuropsychobiology. 2002;45 Suppl 1:33\u20136.","journal-title":"Neuropsychobiology"},{"issue":"3","key":"431_CR35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/da.20038","volume":"20","author":"P Cassano","year":"2004","unstructured":"Cassano P, Lattanzi L, Soldani F, et al. Pramipexole in treatment-resistant depression: an extended follow-up. Depress Anxiety. 2004;20(3):131\u20138.","journal-title":"Depress Anxiety"},{"issue":"3","key":"431_CR36","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/10401230600801176","volume":"18","author":"TA Ketter","year":"2006","unstructured":"Ketter TA, Wang PW, Chandler RA, et al. Adjunctive aripiprazole in treatment-resistant bipolar depression. Ann Clin Psychiatry. 2006;18(3):169\u201372.","journal-title":"Ann Clin Psychiatry"},{"issue":"7","key":"431_CR37","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1399-5618.2007.00532.x","volume":"9","author":"S Roitman","year":"2007","unstructured":"Roitman S, Green T, Osher Y, et al. Creatine monohydrate in resistant depression: preliminary study. Bipolar Disord. 2007;9(7):754\u20138.","journal-title":"Bipolar Disord"},{"issue":"6","key":"431_CR38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000235985","volume":"78","author":"AA Nierenberg","year":"2009","unstructured":"Nierenberg AA. Low-dose buspirone, melatonin and low-dose bupropion added to mood stabilizers for severe treatment-resistant bipolar depression. Psychother Psychosom. 2009;78(6):391\u20133.","journal-title":"Psychother Psychosom"},{"issue":"3","key":"431_CR39","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jad.2008.12.010","volume":"116","author":"T Kelly","year":"2009","unstructured":"Kelly T, Lieberman DZ. The use of triiodothyronine as an augmentation agent in treatment-resistant bipolar II and bipolar disorder NOS. J Affect Disord. 2009;116(3):222\u20136.","journal-title":"J Affect Disord"},{"issue":"4","key":"431_CR40","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1600-0447.2009.01434.x","volume":"121","author":"G Parker","year":"2010","unstructured":"Parker G, Brotchie H. Do the old psychostimulant drugs have a role in managing treatment-resistant depression? Acta Psychiatr Scand. 2010;121(4):308\u201314.","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"431_CR41","first-page":"17","volume":"23","author":"YM Ahn","year":"2011","unstructured":"Ahn YM, Nam JY, Culver JL, et al. Lamotrigine plus quetiapine combination therapy in treatment-resistant bipolar depression. Ann Clin Psychiatry. 2011;23(1):17\u201324.","journal-title":"Ann Clin Psychiatry"},{"issue":"1\u20133","key":"431_CR42","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jad.2012.09.005","volume":"147","author":"LC Schaffer","year":"2013","unstructured":"Schaffer LC, Schaffer CB, Miller AR, et al. Open trial of pregabalin as an acute and maintenance adjunctive treatment for outpatients with treatment-resistant bipolar disorder. J Affect Disord. 2013;147(1\u20133):407\u201310.","journal-title":"J Affect Disord"},{"issue":"1","key":"431_CR43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/jcp.0b013e3181618eb4","volume":"28","author":"ME Thase","year":"2008","unstructured":"Thase ME, Jonas A, Khan A. Aripiprazole monotherapy in non-psychotic bipolar I depression: results of 2 randomized, placebo-controlled studies. J Clin Psychophrmacol. 2008;28(1):13\u201320.","journal-title":"J Clin Psychophrmacol"},{"key":"431_CR44","doi-asserted-by":"crossref","unstructured":"Selle V, Schalkwijk S, V\u00e1zquez GH, Baldessarini RJ. Treatments for acute bipolar depression: meta-analyses of placebo-controlled trials of mood-stabilizers and second-generation antipsychotics. Pharmacopsychiatry 2013; in press.","DOI":"10.1055\/s-0033-1363258"},{"issue":"3","key":"431_CR45","first-page":"356","volume":"72","author":"HA Swartz","year":"2011","unstructured":"Swartz HA, Thase ME. Pharmacotherapy for the treatment of acute bipolar II depression: current evidence. Psychiatry. 2011;72(3):356\u201366.","journal-title":"Psychiatry"},{"issue":"5","key":"431_CR46","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/hup.2253","volume":"27","author":"LS Lorenzo","year":"2012","unstructured":"Lorenzo LS, V\u00e1zquez GH, Zaratiegui RM, et al. Characteristics of bipolar disorder patients given antidepressants. Hum Psychopharmacol. 2012;27(5):486\u201391.","journal-title":"Hum Psychopharmacol"},{"issue":"1","key":"431_CR47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jad.2012.01.027","volume":"139","author":"J Undurraga","year":"2012","unstructured":"Undurraga J, Baldessarini RJ, Valenti M, et al. Bipolar depression: clinical correlates of receiving antidepressants. J Affect Disord. 2012;139(1):89\u201393.","journal-title":"J Affect Disord"},{"issue":"6","key":"431_CR48","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1600-0447.2009.01514.x","volume":"121","author":"L Tondo","year":"2010","unstructured":"\u2022 Tondo L, V\u00e1zquez GH, Baldessarini RJ. Mania associated with antidepressant-treatment: comprehensive meta-analytic review. Acta Psychiatr Scand. 2010;121(6):404\u201314. Meta-analyis of more than 100 studies on the risk of switch in bipolar and unipolar patients, with and without mood-stabilizers.","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"431_CR49","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-244X-10-16","volume":"10","author":"U Kessler","year":"2010","unstructured":"Kessler U, Vaaler AE, Sch\u00f8yen H, et al. Study protocol of the Norwegian randomized controlled trial of electroconvulsive therapy in treatment resistant depression in bipolar disorder. BMC Psychiatry. 2010;10(2):16.","journal-title":"BMC Psychiatry"},{"key":"431_CR50","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4614-3710-9","volume-title":"Chemotherapy in Psychiatry","author":"RJ Baldessarini","year":"2013","unstructured":"Baldessarini RJ. Chemotherapy in Psychiatry. 3rd ed. New York: Springer Press; 2013.","edition":"3"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-013-0431-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11920-013-0431-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-013-0431-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T14:58:35Z","timestamp":1565103515000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11920-013-0431-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,16]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["431"],"URL":"https:\/\/doi.org\/10.1007\/s11920-013-0431-y","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,16]]},"article-number":"431"}}